Claudia S K Kay
Overview
Explore the profile of Claudia S K Kay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gaviraghi T, Cavalcanti E, Lorenzoni P, Cotta A, de Souza P, de Oliveira A, et al.
Clin Genet
. 2024 Jul;
106(5):644-649.
PMID: 39015008
Limb-girdle muscular dystrophy type 2G/R7 (LGMD2G/R7) is an ultra-rare condition initially identified within the Brazilian population. We aimed to expand clinical and genetic information about this disease, including its worldwide...
2.
Fustes O, Kay C, Lorenzoni P, Ducci R, Werneck L, Scola R
J Cent Nerv Syst Dis
. 2022 Jan;
13:11795735211057315.
PMID: 34992486
Background: Neuromyelitis optica spectrum disorders (NMOSDs) are rare antibody-mediated disorders of the central nervous system, with a predilection for the spinal cord and optic nerves. The clinical utility of evoked...
3.
Ducci R, Lorenzoni P, Kay C, Werneck L, Scola R
Neuromuscul Disord
. 2017 Mar;
27(4):352-357.
PMID: 28256306
This study aimed to analyze the outcome and impact of pregnancy in women with myasthenia gravis (MG). Obstetric and clinical data were retrospectively analyzed before, during and after pregnancy. Predictors...
4.
Shen X, Scola R, Lorenzoni P, Kay C, Werneck L, Brengman J, et al.
Ann Clin Transl Neurol
. 2017 Feb;
4(2):130-138.
PMID: 28168212
Objective: To identify the molecular basis and elucidate the pathogenesis of a fatal congenital myasthenic syndrome. Methods: We performed clinical electrophysiology studies, exome and Sanger sequencing, and analyzed functional consequences...
5.
Scola R, Lorenzoni P, Kay C, Werneck L
Arq Neuropsiquiatr
. 2014 Nov;
72(11):897-8.
PMID: 25410460
No abstract available.
6.
Scola R, Lorenzoni P, Kay C, Teive H, Bruck I, Werneck L
Arq Neuropsiquiatr
. 2014 Sep;
72(9):738-9.
PMID: 25252240
No abstract available.
7.
Lorenzoni P, Cardoso E, Crippa A, Lourenco C, Souza F, Giugliani R, et al.
Arq Neuropsiquiatr
. 2014 Mar;
72(3):214-8.
PMID: 24676439
Unlabelled: The aim of the study was to analyze a series of Brazilian patients with Niemann-Pick disease type C (NP-C). Method: Correlations between clinical findings, laboratory data, molecular findings and...
8.
Braatz V, Lorenzoni P, Kay C, Chula D, Scola R, Werneck L
Arq Neuropsiquiatr
. 2014 Mar;
72(1):83-4.
PMID: 24637987
No abstract available.
9.
Braatz V, Kay C, Lorenzoni P, Ludwig V, Junior M, Ioshii S, et al.
Arq Neuropsiquiatr
. 2013 Oct;
71(9A):643-4.
PMID: 24141446
No abstract available.
10.
Lorenzoni P, Scola R, Kay C, Filla L, Miranda A, Pinheiro J, et al.
J Neurol Sci
. 2013 Jun;
331(1-2):155-7.
PMID: 23790237
Introduction: Salbutamol is a selective B2-adrenergic agonist, which has previously been described to be associated with partial improvement of myasthenia gravis and congenital myasthenic syndromes (CMS). In this study, we...